Bertrand William C JR

Bertrand William C JR is listed in filings as Chief Operating Officer at Adaptimmune Therapeutics plc. This profile follows SEC Form 4 activity through Aug 29, 2025, including sale activity. Recent filings connect the profile to Adaptimmune Therapeutics plc (ADAPY) and Ardelyx, Inc. (ARDX). The current snapshot covers public activity from Jun 17, 2024 to Aug 29, 2025. Reported amounts are shown as $2.1K to $1.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.